期刊文献+

Gastrointestinal complications of diabetes mellitus 被引量:14

Gastrointestinal complications of diabetes mellitus
在线阅读 下载PDF
导出
摘要 Diabetes mellitus affects virtually every organ system in the body and the degree of organ involvement depends on the duration and severity of the disease,and other co-morbidities.Gastrointestinal(GI) involvement can present with esophageal dysmotility,gastro-esophageal reflux disease(GERD),gastroparesis,enteropathy,non alcoholic fatty liver disease(NAFLD) and glycogenic hepatopathy.Severity of GERD is inversely related to glycemic control and management is with prokinetics and proton pump inhibitors.Diabetic gastroparesis manifests as early satiety,bloating,vomiting,abdominal pain and erratic glycemic control.Gastric emptying scintigraphy is considered the gold standard test for diagnosis.Management includes dietary modifications,maintaining euglycemia,prokinetics,endoscopic and surgical treatments.Diabetic enteropathy is also common and management involves glycemic control and symptomatic measures.NAFLD is considered a hepatic manifestation of metabolic syndrome and treatment ismainly lifestyle measures,with diabetes and dyslipidemia management when coexistent.Glycogenic hepatopathy is a manifestation of poorly controlled type 1 diabetes and is managed by prompt insulin treatment.Though GI complications of diabetes are relatively common,awareness about its manifestations and treatment options are low among physicians.Optimal management of GI complications is important for appropriate metabolic control of diabetes and improvement in quality of life of the patient.This review is an update on the GI complications of diabetes,their pathophysiology,diagnostic evaluation and management. Diabetes mellitus affects virtually every organ system in the body and the degree of organ involvement depends on the duration and severity of the disease,and other co-morbidities.Gastrointestinal(GI) involvement can present with esophageal dysmotility,gastro-esophageal reflux disease(GERD),gastroparesis,enteropathy,non alcoholic fatty liver disease(NAFLD) and glycogenic hepatopathy.Severity of GERD is inversely related to glycemic control and management is with prokinetics and proton pump inhibitors.Diabetic gastroparesis manifests as early satiety,bloating,vomiting,abdominal pain and erratic glycemic control.Gastric emptying scintigraphy is considered the gold standard test for diagnosis.Management includes dietary modifications,maintaining euglycemia,prokinetics,endoscopic and surgical treatments.Diabetic enteropathy is also common and management involves glycemic control and symptomatic measures.NAFLD is considered a hepatic manifestation of metabolic syndrome and treatment ismainly lifestyle measures,with diabetes and dyslipidemia management when coexistent.Glycogenic hepatopathy is a manifestation of poorly controlled type 1 diabetes and is managed by prompt insulin treatment.Though GI complications of diabetes are relatively common,awareness about its manifestations and treatment options are low among physicians.Optimal management of GI complications is important for appropriate metabolic control of diabetes and improvement in quality of life of the patient.This review is an update on the GI complications of diabetes,their pathophysiology,diagnostic evaluation and management.
出处 《World Journal of Diabetes》 SCIE CAS 2013年第3期51-63,共13页 世界糖尿病杂志(英文版)(电子版)
关键词 Gastrointestinal COMPLICATIONS Diabetes mellitus Esophageal COMPLICATIONS NONALCOHOLIC fatty liver disease DIABETIC GASTROPARESIS DIABETIC ENTEROPATHY Glycogenic HEPATOPATHY Gastrointestinal complications Diabetes mellitus Esophageal complications Nonalcoholic fatty liver disease Diabetic gastroparesis Diabetic enteropathy Glycogenic hepatopathy
  • 相关文献

参考文献115

  • 1Kalpana Ravella,Hong Yang,Pandu R. R. Gangula.Impairment of Gastric Nitrergic and NRF2 System in Apolipoprotein E Knockout Mice[J]. Digestive Diseases and Sciences . 2012 (6)
  • 2Etsushi Kawamura,Masaru Enomoto,Kohei Kotani,Atsushi Hagihara,Hideki Fujii,Sawako Kobayashi,Shuji Iwai,Hiroyasu Morikawa,Joji Kawabe,Kazunari Tominaga,Akihiro Tamori,Susumu Shiomi,Norifumi Kawada.Effect of Mosapride Citrate on Gastric Emptying in Interferon-Induced Gastroparesis[J]. Digestive Diseases and Sciences . 2012 (6)
  • 3G. Musso,M. Cassader,F. Rosina,R. Gambino.Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials[J]. Diabetologia . 2012 (4)
  • 4Radoslav Coleski,Michelle A. Anderson,William L. Hasler.Factors Associated with Symptom Response to Pyloric Injection of Botulinum Toxin in a Large Series of Gastroparesis Patients[J]. Digestive Diseases and Sciences . 2009 (12)
  • 5Rayner CK,Samsom M,Jones KL, et al.Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care . 2001
  • 6Ordog T,Takayama I,Cheung WK,et al.Remodeling of networks of interstitial cell of Cajal in a murine model of diabetic gastroparesis. Diabetes . 2000
  • 7Mearin F,Camilleri M,Malagelada JR.Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology . 1986
  • 8Marchesini G,Brizi M,Morselli-Labate AM,et al.Association of nonalcoholic fatty liver disease with insulin resistance. American Journal of Medicine . 1999
  • 9James O,Day C.Non-alcoholic steatohepatitis: another disease of affluence. Lancet,The . 1999
  • 10Marchesini G,Bugianesi E,Forlani G,et al.Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology . 2003

二级参考文献51

  • 1[1]Rundles RW.Diabetic Neuropathy.Medicine 1945; 24:111-160
  • 2[2]Ko GT,Chan WB,Chan JC,Tsang LW,Cockram CS.Gastrointestinal symptoms in Chinese patients with Type 2 diabetes mellitus.Diabet Med 1999; 16:670-674
  • 3[3]Folwaczny C,Riepl R,Tschop M,Landgraf R.Gastrointestinal involvement in patients with diabetes mellitus:Part Ⅰ (first of two parts).Epidemiology,pathophysiology,clinical findings.Z Gastroenterol 1999; 37:803-815
  • 4[4]Spangeus A,El-Salhy M,Suhr O,Eriksson J,Lithner F.Prevalence of gastrointestinal symptoms in young and middleaged diabetic patients.Scand J Gastroenterol 1999; 34:1196-1202
  • 5[5]Horowitz M,Samsom M.Gastrointestinal Function in Diabetes Mellius.Chichester:John Wiley & Sons Ltd.,2004:1-27
  • 6[6]Mearin F,Malagelada JR.Gastroparesis and dyspepsia in patients with diabetes mellitus.Eur J Gastroenterol Hepatol 1995; 7:717-723
  • 7[7]Horowitz M,Edelbroek M,Fraser R,Maddox A,Wishart J.Disordered gastric motor function in diabetes mellitus.Recent insights into prevalence,pathophysiology,clinical relevance,and treatment.Scand J Gastroenterol 1991; 26:673-684
  • 8[8]Britland ST,Young RJ,Sharma AK,Lee D,Ah-See AK,Clarke BF.Vagus nerve morphology in diabetic gastropathy.Diabet Med 1990; 7:780-787
  • 9[9]Holtmann G,Goebell H,Talley NJ.Gastrointestinal sensory function in functional dyspepsia.Gastroenterology 1995; 109:331-332
  • 10[10]Samsom M,Salet GA,Roelofs JM,Akkermans LM,VanbergeHenegouwen GP,Smout AJ.Compliance of the proximal stomach and dyspeptic symptoms in patients with type Ⅰ diabetes mellitus.Dig Dis Sci 1995; 40:2037-2042

共引文献31

同被引文献75

引证文献14

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部